dalteparin has been researched along with Carcinoma, Small Cell Lung in 5 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We present a rare case of a thrombus at the aortic arch found 1 month after cisplatin-based chemotherapy in a 50-year-old patient with a diagnosis of small cell lung cancer; there were no symptoms related to the thrombus." | 1.36 | Aortic thrombosis resolved with enoxaparin in a patient treated with cisplatin-based regimen for small cell lung cancer. ( Baek, SK; Chin, SO; Choi, CW; Han, JJ; Hwang, YH; Lee, JJ; Maeng, CH, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lecumberri, R | 1 |
| López Vivanco, G | 1 |
| Font, A | 1 |
| González Billalabeitia, E | 1 |
| Gúrpide, A | 1 |
| Gómez Codina, J | 1 |
| Isla, D | 1 |
| Galán, A | 1 |
| Bover, I | 1 |
| Domine, M | 1 |
| Vicente, V | 1 |
| Rosell, R | 1 |
| Rocha, E | 1 |
| Ek, L | 2 |
| Gezelius, E | 2 |
| Bergman, B | 2 |
| Bendahl, PO | 2 |
| Anderson, H | 1 |
| Sundberg, J | 2 |
| Wallberg, M | 1 |
| Falkmer, U | 1 |
| Verma, S | 1 |
| Belting, M | 2 |
| Gonçalves de Oliveira, K | 1 |
| Strandberg, K | 1 |
| Krämer, R | 1 |
| Chin, SO | 1 |
| Lee, JJ | 1 |
| Hwang, YH | 1 |
| Han, JJ | 1 |
| Maeng, CH | 1 |
| Baek, SK | 1 |
| Choi, CW | 1 |
| Gamperl, H | 1 |
| Plattfaut, C | 1 |
| Freund, A | 1 |
| Quecke, T | 1 |
| Theophil, F | 1 |
| Gieseler, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Multicenter, Randomized, Open and Sequential Study to Evaluate the Efficacy and Safety of Bemiparin Administration on the Response to Treatment in Patients Diagnosed With Limited Small Cell Lung Cancer[NCT00324558] | Phase 2 | 39 participants (Actual) | Interventional | 2005-06-30 | Terminated (stopped due to Sponsor stopped due to difficulties to recruit 130 patients required by protocol) | ||
| A Randomized Phase III Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer[NCT00717938] | Phase 3 | 390 participants (Actual) | Interventional | 2008-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for dalteparin and Carcinoma, Small Cell Lung
| Article | Year |
|---|---|
Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: results from the ABEL study.
Topics: Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; | 2013 |
Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer: the RASTEN trial.
Topics: Aged; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Enoxaparin; Female; Hemorrhage | 2018 |
Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN).
Topics: Aged; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation; Blood Coagu | 2019 |
2 other studies available for dalteparin and Carcinoma, Small Cell Lung
| Article | Year |
|---|---|
Aortic thrombosis resolved with enoxaparin in a patient treated with cisplatin-based regimen for small cell lung cancer.
Topics: Anticoagulants; Antineoplastic Agents; Aorta; Cisplatin; Enoxaparin; Humans; Lung Neoplasms; Male; M | 2010 |
Extracellular vesicles from malignant effusions induce tumor cell migration: inhibitory effect of LMWH tinzaparin.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Movement; Colorectal Neoplasms; Endothelium, Vascular; Epit | 2016 |